Compound details
Bisacutifolone C
| Compound ID | CDAMM02291 |
|---|---|
| Common name | Bisacutifolone C | IUPAC name | methyl 5-(7a-methoxycarbonyl-1,3a,4-trimethyl-7-oxo-1,2,3,4-tetrahydroinden-5-yl)-3,9,9a-trimethyl-4-oxo-1,2,3,5,6,7,8,9-octahydrocyclopenta[b]naphthalene-3a-carboxylate |
| Molecular formula | C32H44O6 |
| Retention time | 4.51 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 525.32 | Theoretical mz | 525.321 |
| Error | 1.48 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.7265 |
| Inchi key | YHAMPUKPFZHPOZ-CMOUCNCINA-N |
|---|---|
| Smiles | O=C(OC)C12C(=O)C=C(C3C=4C(=O)C5(C(=O)OC)C(C)CCC5(C)C(C4CCC3)C)C(C)C2(C)CCC1C |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P06239 | LCK | Tyrosine-protein kinase LCK | T12499 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SwissTargetPrediction |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction |
| P28222 | HTR1B | Serotonin 1b (5-HT1b) receptor | T07806 | SwissTargetPrediction |
| P28221 | HTR1D | Serotonin 1d (5-HT1d) receptor | T11072 | SwissTargetPrediction |
| P08588 | ADRB1 | Beta-1 adrenergic receptor | T44068 | SwissTargetPrediction |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| P56524 | HDAC4 | Histone deacetylase 4 | T63816 | SwissTargetPrediction |
| P43235 | CTSK | Cathepsin K | T11388 | SwissTargetPrediction |
| Q9UBN7 | HDAC6 | Histone deacetylase 6 | T22274 | SwissTargetPrediction |
| P07384 | CAPN1 | Calpain 1 | T92517 | SwissTargetPrediction |
| P35354 | PTGS2 | Cyclooxygenase-2 | T66665 | SwissTargetPrediction |
| P10275 | AR | Androgen Receptor | T11211 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P04150 | NR3C1 | Glucocorticoid receptor | T40016 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P25021 | HRH2 | Histamine H2 receptor | T30985 | SwissTargetPrediction |
| P35367 | HRH1 | Histamine H1 receptor | T77913 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| Q8TDU6 | GPBAR1 | G-protein coupled bile acid receptor 1 | T86273 | SwissTargetPrediction |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SwissTargetPrediction |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SwissTargetPrediction |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SwissTargetPrediction |
| Q15465 | SHH | Sonic hedgehog protein (by homology) | T12075 | SwissTargetPrediction |
| Q13547 | HDAC1 | Histone deacetylase 1 | T68547 | SwissTargetPrediction |
| P17655 | CAPN2 | Calpain 2 | T86837 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P21728 | DRD1 | Dopamine D1 receptor | T22118 | SwissTargetPrediction |
| P07550 | ADRB2 | Adrenergic receptor beta | T52522 | SwissTargetPrediction |
| P18825 | ADRA2C | Adrenergic receptor alpha-2 | T01777 | SwissTargetPrediction |
| P25100 | ADRA1D | Alpha-1d adrenergic receptor | T53381 | SwissTargetPrediction |
| P35368 | ADRA1B | Alpha-1b adrenergic receptor | T29500 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P35270 | SPR | Substance-P receptor | T47094 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| P04229 | HLA-DRB1 | HLA class II histocompatibility antigen DRB1-1 | T83611 | SwissTargetPrediction |
| P07711 | CTSL | Cathepsin L | T98691 | SwissTargetPrediction |
| O43603 | GALR2 | Galanin receptor 2 (by homology) | T13453 | SwissTargetPrediction |
| P47211 | GALR1 | Galanin receptor 1 (by homology) | T78581 | SwissTargetPrediction |
| P07858 | CTSB | Cathepsin (B and K) | T61746 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P35348 | ADRA1A | Alpha-1a adrenergic receptor | T92609 | SwissTargetPrediction |
| Q15858 | SCN9A | Sodium channel protein type IX alpha subunit | T12119 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| Q9Y5Y9 | SCN10A | Sodium channel protein type X alpha subunit (by homology) | T43739 | SwissTargetPrediction |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SwissTargetPrediction |
| P25774 | CTSS | Cathepsin S | T68290 | SwissTargetPrediction |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P04629 | NTRK1 | Nerve growth factor receptor Trk-A | T07173 | SwissTargetPrediction |
| P11597 | CETP | Cholesteryl ester transfer protein | T15334 | SwissTargetPrediction |
| Q99835 | SMO | Smoothened homolog | T66505 | SwissTargetPrediction |
| O00763 | ACACB | Acetyl-CoA carboxylase 2 | T08922 | SwissTargetPrediction |
| P32745 | SSTR3 | Somatostatin receptor 3 | T13644 | SwissTargetPrediction |
| P50052 | AGTR2 | Angiotensin II receptor | T09909 | SwissTargetPrediction |
| P32239 | CCKBR | Cholecystokinin B receptor (by homology) | T05849 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| P48067 | SLC6A9 | Glycine transporter 1 | T69685 | SwissTargetPrediction |
| Q16602 | CALCRL | Calcitonin gene-related peptide type 1 receptor | T02226 | SwissTargetPrediction |
| O75908 | SOAT2 | Acyl coenzyme A:cholesterol acyltransferase 2 | T14463 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| P28074 | PSMB5 | Proteasome Macropain subunit MB1 | T49031 | SwissTargetPrediction |
| P30536 | TSPO | Translocator protein (by homology) | T75440 | SwissTargetPrediction |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SwissTargetPrediction |
| P43490 | NAMPT | Nicotinamide phosphoribosyltransferase | T54582 | SwissTargetPrediction |
| Q14524 | SCN5A | Sodium channel protein type V alpha subunit | T39716 | SwissTargetPrediction |
| P22460 | KCNA5 | Voltage-gated potassium channel subunit Kv1.5 | T17569 | SwissTargetPrediction |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SwissTargetPrediction |
| P00746 | CFD | Complement factor D | T66383 | SwissTargetPrediction |
| P01130 | LDLR | LDL receptor | T94692 | SwissTargetPrediction |
| P29371 | TACR3 | Neurokinin 3 receptor | T29683 | SwissTargetPrediction |
| Q13936 | CACNA1C | Voltage-gated L-type calcium channel alpha-1C subunit | T51115 | SwissTargetPrediction |
| P03951 | F11 | Coagulation factor XI | T46040 | SwissTargetPrediction |
| O43497 | CACNA1G | Voltage-gated T-type calcium channel alpha-1G subunit | T64795 | SwissTargetPrediction |
| O95180 | CACNA1H | Voltage-gated T-type calcium channel alpha-1H subunit | T54644 | SwissTargetPrediction |
| P49682 | CXCR3 | C-X-C chemokine receptor type 3 | T25315 | SwissTargetPrediction |
| Q99500 | S1PR3 | Sphingosine 1-phosphate receptor Edg-3 | T11241 | SwissTargetPrediction |
| P33316 | DUT | dUTP pyrophosphatase | T39054 | SwissTargetPrediction |
| P25963 | NFKBIA | NF-kappaB inhibitor alpha | T51672 | SwissTargetPrediction |
| Q10469 | MGAT2 | Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | T67812 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T12499 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06239 | LCK |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T07806 | DI0264 | Migraine | [ICD-11: 8A80] | P28222 | HTR1B |
| T07806 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28222 | HTR1B |
| T07806 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P28222 | HTR1B |
| T07806 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28222 | HTR1B |
| T11072 | DI0264 | Migraine | [ICD-11: 8A80] | P28221 | HTR1D |
| T11072 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28221 | HTR1D |
| T44068 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P08588 | ADRB1 |
| T44068 | DI0037 | Asthma | [ICD-11: CA23] | P08588 | ADRB1 |
| T44068 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | P08588 | ADRB1 |
| T44068 | DI0071 | Central and peripheral nervous disease | [ICD-11: 8A04-8E7Z] | P08588 | ADRB1 |
| T44068 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P08588 | ADRB1 |
| T44068 | DI0097 | Conduction disorder | [ICD-11: BC63] | P08588 | ADRB1 |
| T44068 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P08588 | ADRB1 |
| T44068 | DI0137 | Essential hypertension | [ICD-11: BA00] | P08588 | ADRB1 |
| T44068 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08588 | ADRB1 |
| T44068 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08588 | ADRB1 |
| T44068 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08588 | ADRB1 |
| T44068 | DI0264 | Migraine | [ICD-11: 8A80] | P08588 | ADRB1 |
| T44068 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P08588 | ADRB1 |
| T44068 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P08588 | ADRB1 |
| T44068 | DI0434 | Ventricular tachyarrhythmia | [ICD-11: BC71] | P08588 | ADRB1 |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T63816 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P56524 | HDAC4 |
| T11388 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P43235 | CTSK |
| T22274 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9UBN7 | HDAC6 |
| T22274 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UBN7 | HDAC6 |
| T66665 | DI0087 | Chronic pain | [ICD-11: MG30] | P35354 | PTGS2 |
| T66665 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P35354 | PTGS2 |
| T66665 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P35354 | PTGS2 |
| T66665 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P35354 | PTGS2 |
| T66665 | DI0227 | Knee osteoarthritis | [ICD-11: FA01] | P35354 | PTGS2 |
| T66665 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35354 | PTGS2 |
| T66665 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35354 | PTGS2 |
| T66665 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35354 | PTGS2 |
| T66665 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P35354 | PTGS2 |
| T11211 | DI0005 | Acne vulgaris | [ICD-11: ED80] | P10275 | AR |
| T11211 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10275 | AR |
| T11211 | DI0021 | Alcoholic liver disease | [ICD-11: DB94] | P10275 | AR |
| T11211 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P10275 | AR |
| T11211 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P10275 | AR |
| T11211 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P10275 | AR |
| T11211 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P10275 | AR |
| T11211 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P10275 | AR |
| T11211 | DI0247 | Mammary tumour | [ICD-11: 2C60-2C6Z] | P10275 | AR |
| T11211 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P10275 | AR |
| T11211 | DI0401 | Testicular dysfunction | [ICD-11: 5A81] | P10275 | AR |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T40016 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P04150 | NR3C1 |
| T40016 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P04150 | NR3C1 |
| T40016 | DI0037 | Asthma | [ICD-11: CA23] | P04150 | NR3C1 |
| T40016 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P04150 | NR3C1 |
| T40016 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P04150 | NR3C1 |
| T40016 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04150 | NR3C1 |
| T40016 | DI0314 | Oesophagitis | [ICD-11: DA24] | P04150 | NR3C1 |
| T40016 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P04150 | NR3C1 |
| T40016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P04150 | NR3C1 |
| T40016 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04150 | NR3C1 |
| T40016 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P04150 | NR3C1 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T30985 | DI0161 | Gastro-oesophageal reflux disease | [ICD-11: DA22] | P25021 | HRH2 |
| T30985 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P25021 | HRH2 |
| T30985 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P25021 | HRH2 |
| T77913 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P35367 | HRH1 |
| T77913 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P35367 | HRH1 |
| T77913 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P35367 | HRH1 |
| T77913 | DI0099 | Conjunctiva disorder | [ICD-11: 9A60] | P35367 | HRH1 |
| T77913 | DI0105 | Cough | [ICD-11: MD12] | P35367 | HRH1 |
| T77913 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35367 | HRH1 |
| T77913 | DI0136 | Episodic vestibular syndrome | [ICD-11: AB31] | P35367 | HRH1 |
| T77913 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P35367 | HRH1 |
| T77913 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P35367 | HRH1 |
| T77913 | DI0272 | Morning sickness disorder | [ICD-11: SC00] | P35367 | HRH1 |
| T77913 | DI0292 | Nasopharyngitis | [ICD-11: CA00] | P35367 | HRH1 |
| T77913 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35367 | HRH1 |
| T77913 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35367 | HRH1 |
| T77913 | DI0349 | Pruritus | [ICD-11: EC90] | P35367 | HRH1 |
| T77913 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35367 | HRH1 |
| T77913 | DI0388 | Sleep-wake disorder | [ICD-11: 7A00-7B2Z] | P35367 | HRH1 |
| T77913 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P35367 | HRH1 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T86273 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q8TDU6 | GPBAR1 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T68547 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q13547 | HDAC1 |
| T68547 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | Q13547 | HDAC1 |
| T86837 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P17655 | CAPN2 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T22118 | DI0003 | Abortion | [ICD-11: JA00] | P21728 | DRD1 |
| T22118 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21728 | DRD1 |
| T22118 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P21728 | DRD1 |
| T22118 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21728 | DRD1 |
| T52522 | DI0037 | Asthma | [ICD-11: CA23] | P07550 | ADRB2 |
| T52522 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07550 | ADRB2 |
| T52522 | DI0097 | Conduction disorder | [ICD-11: BC63] | P07550 | ADRB2 |
| T52522 | DI0344 | Preterm labour/delivery | [ICD-11: JB00] | P07550 | ADRB2 |
| T52522 | DI0387 | Sleep-related breathing disorder | [ICD-11: 7A4Z] | P07550 | ADRB2 |
| T01777 | DI0166 | Glaucoma | [ICD-11: 9C61] | P18825 | ADRA2C |
| T01777 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P18825 | ADRA2C |
| T01777 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P18825 | ADRA2C |
| T01777 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18825 | ADRA2C |
| T01777 | DI0310 | Ocular disease | [ICD-11: N.A.] | P18825 | ADRA2C |
| T01777 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18825 | ADRA2C |
| T53381 | DI0166 | Glaucoma | [ICD-11: 9C61] | P25100 | ADRA1D |
| T53381 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P25100 | ADRA1D |
| T53381 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P25100 | ADRA1D |
| T53381 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P25100 | ADRA1D |
| T53381 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P25100 | ADRA1D |
| T53381 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P25100 | ADRA1D |
| T29500 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P35368 | ADRA1B |
| T29500 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35368 | ADRA1B |
| T29500 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P35368 | ADRA1B |
| T29500 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P35368 | ADRA1B |
| T29500 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35368 | ADRA1B |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T83611 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P04229 | HLA-DRB1 |
| T98691 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P07711 | CTSL |
| T98691 | DI0376 | Severe acute respiratory syndrome | [ICD-11: 1D65] | P07711 | CTSL |
| T78581 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P47211 | GALR1 |
| T61746 | DI0023 | Alopecia | [ICD-11: ED70] | P07858 | CTSB |
| T61746 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P07858 | CTSB |
| T61746 | DI0037 | Asthma | [ICD-11: CA23] | P07858 | CTSB |
| T61746 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | P07858 | CTSB |
| T61746 | DI0060 | Brain cancer | [ICD-11: 2A00] | P07858 | CTSB |
| T61746 | DI0067 | Cardiac arrest | [ICD-11: MC82] | P07858 | CTSB |
| T61746 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P07858 | CTSB |
| T61746 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07858 | CTSB |
| T61746 | DI0087 | Chronic pain | [ICD-11: MG30] | P07858 | CTSB |
| T61746 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P07858 | CTSB |
| T61746 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P07858 | CTSB |
| T61746 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P07858 | CTSB |
| T61746 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P07858 | CTSB |
| T61746 | DI0253 | Meningioma | [ICD-11: 2A01] | P07858 | CTSB |
| T61746 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P07858 | CTSB |
| T61746 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07858 | CTSB |
| T61746 | DI0296 | Neurodegenerative disorder | [ICD-11: 8A20-8A23] | P07858 | CTSB |
| T61746 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P07858 | CTSB |
| T61746 | DI0351 | Psoriasis | [ICD-11: EA90] | P07858 | CTSB |
| T61746 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P07858 | CTSB |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T92609 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35348 | ADRA1A |
| T92609 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P35348 | ADRA1A |
| T12119 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q15858 | SCN9A |
| T12119 | DI0087 | Chronic pain | [ICD-11: MG30] | Q15858 | SCN9A |
| T12119 | DI0140 | Extremities vasodilatation | [ICD-11: EG00] | Q15858 | SCN9A |
| T12119 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q15858 | SCN9A |
| T12119 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q15858 | SCN9A |
| T12119 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q15858 | SCN9A |
| T12119 | DI0358 | Radiculopathy | [ICD-11: 8B93] | Q15858 | SCN9A |
| T12119 | DI0415 | Trigeminal nerve disorder | [ICD-11: 8B82] | Q15858 | SCN9A |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T43739 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q9Y5Y9 | SCN10A |
| T43739 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | Q9Y5Y9 | SCN10A |
| T43739 | DI0374 | Sensation disturbance | [ICD-11: MB40] | Q9Y5Y9 | SCN10A |
| T43739 | DI0396 | Substance abuse | [ICD-11: 6C40] | Q9Y5Y9 | SCN10A |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T68290 | DI0042 | Autoimmune disease | [ICD-11: 4A40-4A45] | P25774 | CTSS |
| T68290 | DI0092 | Coeliac disease | [ICD-11: DA95] | P25774 | CTSS |
| T68290 | DI0107 | Crohn disease | [ICD-11: DD70] | P25774 | CTSS |
| T68290 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P25774 | CTSS |
| T68290 | DI0163 | General pain disorder | [ICD-11: 8E43] | P25774 | CTSS |
| T68290 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25774 | CTSS |
| T68290 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P25774 | CTSS |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T07173 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04629 | NTRK1 |
| T07173 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04629 | NTRK1 |
| T15334 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P11597 | CETP |
| T15334 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P11597 | CETP |
| T15334 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P11597 | CETP |
| T15334 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P11597 | CETP |
| T66505 | DI0047 | Basal cell carcinoma | [ICD-11: 2C32] | Q99835 | SMO |
| T66505 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | Q99835 | SMO |
| T66505 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99835 | SMO |
| T08922 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O00763 | ACACB |
| T13644 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P32745 | SSTR3 |
| T09909 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P50052 | AGTR2 |
| T09909 | DI0373 | Secondary hypertension | [ICD-11: BA04] | P50052 | AGTR2 |
| T05849 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P32239 | CCKBR |
| T05849 | DI0327 | Pancreatic internal secretion disorder | [ICD-11: 5A4Y] | P32239 | CCKBR |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T69685 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P48067 | SLC6A9 |
| T14463 | DI0017 | Adrenal cancer | [ICD-11: 2D11] | O75908 | SOAT2 |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T75440 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P30536 | TSPO |
| T75440 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P30536 | TSPO |
| T75440 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P30536 | TSPO |
| T75440 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P30536 | TSPO |
| T75440 | DI0271 | Mood/affect symptom | [ICD-11: MB24] | P30536 | TSPO |
| T75440 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P30536 | TSPO |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T54582 | DI0231 | Leukaemia | [ICD-11: 2A60-2B33] | P43490 | NAMPT |
| T54582 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P43490 | NAMPT |
| T54582 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P43490 | NAMPT |
| T39716 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q14524 | SCN5A |
| T39716 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | Q14524 | SCN5A |
| T39716 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q14524 | SCN5A |
| T39716 | DI0105 | Cough | [ICD-11: MD12] | Q14524 | SCN5A |
| T39716 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | Q14524 | SCN5A |
| T39716 | DI0264 | Migraine | [ICD-11: 8A80] | Q14524 | SCN5A |
| T39716 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q14524 | SCN5A |
| T39716 | DI0434 | Ventricular tachyarrhythmia | [ICD-11: BC71] | Q14524 | SCN5A |
| T17569 | DI0030 | Angina pectoris | [ICD-11: BA40] | P22460 | KCNA5 |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T66383 | DI0170 | Haemolytic anemia | [ICD-11: 3A20-3A2Z] | P00746 | CFD |
| T66383 | DI0365 | Retinopathy | [ICD-11: 9B71] | P00746 | CFD |
| T94692 | DI0238 | Lung cancer | [ICD-11: 2C25] | P01130 | LDLR |
| T29683 | DI0254 | Menopausal disorder | [ICD-11: GA30] | P29371 | TACR3 |
| T51115 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q13936 | CACNA1C |
| T46040 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P03951 | F11 |
| T46040 | DI0089 | Clotting disorder | [ICD-11: 3B4Z] | P03951 | F11 |
| T64795 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O43497 | CACNA1G |
| T64795 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | O43497 | CACNA1G |
| T64795 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | O43497 | CACNA1G |
| T64795 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O43497 | CACNA1G |
| T64795 | DI0370 | Schizophrenia | [ICD-11: 6A20] | O43497 | CACNA1G |
| T54644 | DI0004 | Acidosis | [ICD-11: 5C73] | O95180 | CACNA1H |
| T54644 | DI0264 | Migraine | [ICD-11: 8A80] | O95180 | CACNA1H |
| T25315 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P49682 | CXCR3 |
| T25315 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P49682 | CXCR3 |
| T25315 | DI0351 | Psoriasis | [ICD-11: EA90] | P49682 | CXCR3 |
| T25315 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49682 | CXCR3 |
| T11241 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q99500 | S1PR3 |
| T39054 | DI0238 | Lung cancer | [ICD-11: 2C25] | P33316 | DUT |
| T39054 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P33316 | DUT |
| T51672 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P25963 | NFKBIA |